The DGKζ-selective inhibitor ASP1570 similarly enhances NK cell function through DAG-mediated signaling in immunoreceptor-stimulated NK cells, resulting in increased IFNγ production and degranulation in vitro, as well as improved NK cell-mediated tumor clearance in vivo [181]. The gene discussed is DGKZ; the disease is neoplasm.